VPOR News 0.0640 06/11/2014 05:35:35 Vapor Group Inc. (VPOR)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vapor Group Inc. (VPOR) 0.0640 $VPOR

Vapor Group, Inc., VPOR, Announces Opening of "Total Vapor" Company Retail Stores and Expanded "Direct-to-Customer" Retail Strategy
Marketwire - Tue May 27, 3:20PM CDT
Vapor Group, Inc. (OTCQB: VPOR), (the "Company," "Vapor Group", announced today that it had signed four new leases for retail stores in high traffic, major metropolitan areas in Florida. Three of the new stores will be open by the end of June, and the fourth by the end of August. All the stores will be under the "Total Vapor" brand as part of the rollout of an expanded "brick-and-mortar" and online retail strategy for the Company's several brands.

ERBB Selects SmarterSign To Deliver Ads On ZaZZZ Units
ACCESSWIRE - Tue May 27, 7:47AM CDT
Tranzbyte Corp. (OTCPINK: ERBB), now known as American Green, saw its share price close at $.0325, up 8.7% from its previous close of $.0299.

Triton Distribution Systems Sees Share Volume Slide Along With Rest of Marijuana Industry
ACCESSWIRE - Tue May 20, 8:04AM CDT
Triton Distribution Systems, Inc. (OTCPINK: TTDZ) saw its share volume dip on May 19th with 50,747,656 shares exchanging hands, slightly lower than its three month daily average volume of 63,022,166 shares.

Vapor Group, Inc. Will Start Test Marketing CBD Oil E-liquid For Vaping
ACCESSWIRE - Thu May 15, 7:59AM CDT
Vapor Group, Inc. (OTCQB: VPOR) saw its share volume dip on May 14th with 4,120,597 shares exchanging hands, significantly lower than its three month daily share volume of 17,487,719 shares.

Vapor Group, Inc., VPOR, Releases Preliminary Results for First Quarter 2014
Marketwire - Thu May 15, 7:26AM CDT
Vapor Group, Inc. (OTCQB: VPOR), (the "Company", "Vapor Group", released today a preliminary statement about its first quarter 2014 operating results.

Vapor Group, Inc., VPOR, Subsidiary to Begin Test Marketing Direct Sales of E-Liquid Containing CBD Oil
Marketwire - Wed May 14, 7:17AM CDT
Vapor Group, Inc., (OTCQB: VPOR), (the "Company", "Vapor Group", announced that its subsidiary, American Vaporizer, in the next few weeks will start test marketing an e-liquid for vaping containing CBD (cannabidiol) oil.

Vapor Group Defends Position as Stock Continues to Slide
at The Street - Fri May 09, 2:24PM CDT
A video by TheStreet earlier this week covering Vapor Group's private placement triggered a public response from the company. The company's response also triggered an angry Twitter campaign defending Vapor Group.

Vapor Group, Inc., VPOR, Thanks and Responds to "TheStreet.Com"
Marketwire - Wed May 07, 9:45AM CDT
Background

Vapor Group, Inc., VPOR, Closes $1,235,000 Private Placement for Business Expansion
Marketwire - Wed May 07, 5:04AM CDT
Vapor Group, Inc. (OTCQB: VPOR), (the "Company," "Vapor Group" announced today that it had closed a private placement with Hanover Holdings I, LLC ("Hanover", an affiliate of Magna Group ("Magna", in aggregate principal amount of $1,342,391.17 in 8% Senior Convertible Notes ("Notes" due twelve months from the date of issuance. The Notes were purchased by Hanover for $1,235,000. Proceeds from the Notes will be used by the Company to expand its business by, among other things, increasing product inventories for its brands and for expansion of the sales and marketing of its newly acquired subsidiary, American Vaporizer, LLC, including the purchase of additional inventories of product and e-liquids for its "American Smoke" brand.

Vapor Hub International Inc. Trades High Volume Yesterday
ACCESSWIRE - Tue May 06, 10:37AM CDT
Vapor Hub International Inc.'s (OTCQB: VHUB) share volume skyrocketed on May 5th, with 3,650,425 shares exchanging hands, significantly higher than its three month average daily volume of 559,134.

Medical Marijuana Stocks Trading Down
ACCESSWIRE - Fri May 02, 9:13AM CDT
US Energy Initiative Corporation, Inc.'s (OTCPINK: USEI) stock volume soared on May 1st, with 87,648,064 shares changing hands, 38% higher than its three month average volume of 63,211,905.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Kearney's 2025 Global Cities Report Insights

Updated Category News Views 654

Global Cities Adapt to New Challenges and Emergence Global cities hold steady at the top as new hubs surge forward Top cities reaffirm their dominance in the Global Cities Index, showcasing remarkable resilience amidst global changes and uncertainties. The Global Cities Outlook indicates a noticeable shift as traditional leaders face turbulence, while emerging Gulf and...

Continue Reading
Vacca Family Law Group Enhances Support for Peaceful Divorce

Updated Category News Views 255

Empowering Families Through Non-Adversarial Divorce Solutions Families navigating the challenging process of separation now have renewed access to considerate and non-confrontational divorce options. Vacca Family Law Group has recently welcomed Attorney and Mediator Wendy Reimer, who brings nearly two decades of experience in family law and a strong background in...

Continue Reading
Ingredion Delivers Impressive Q3 Results, Upgrades Outlook

Updated Category News Views 55

Ingredion's Strong Performance in the Third Quarter Ingredion Incorporated (NYSE: INGR) has reported remarkable results for the third quarter of 2024, showcasing a noteworthy surge in both operating income and earnings per share (EPS). The global leader in ingredient solutions for the food and beverage industry achieved a stunning 26% increase in reported operating income...

Continue Reading
Insight into Learning Technologies Group Plc's Disclosure Mechanism

Updated Category News Views 193

Understanding the Public Opening Position Disclosure Process In the complex world of financial securities, understanding the disclosure requirements can feel daunting. However, the process outlined by the Takeover Code, particularly Rule 8.3, provides a structured approach for individuals and entities holding significant interests in relevant securities. This rule is...

Continue Reading
Avidity Biosciences Set to Inspire with Latest Presentations

Updated Category News Views 191

Avidity Biosciences' Key Presentations at the MDA Conference Avidity Biosciences, Inc. (Nasdaq: RNA), a pioneer in RNA therapeutics, is poised to make a significant impact at the upcoming Clinical and Scientific Conference organized by the Muscular Dystrophy Association (MDA). The event will showcase the latest advancements in the field and highlight groundbreaking...

Continue Reading